Nicholas Adlard

12PUBLICATIONS
22CO-AUTHORS
Gene and molecular therapyComputational neuroscience (incl. mathematical neuroscience and theoretical neuroscience)Regenerative medicine (incl. stem cells)Comparative language studiesSocial epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jul 11, 2024
ENTIMOS: Decision Support Tool Highlights Potential Impact of Non-intravenous Therapies for Multiple Sclerosis on Patient Care via Clinical Scenario Simulation.

Richard Nicholas, Erik Scalfaro, Rachel Dorsey

|Feb 13, 2024
Disutility of Cognitive Processing Speed (CPS) Impairment in the Context of Multiple Sclerosis: A Time Trade-Off (TTO) Elicitation Study.

Ralph H B Benedict, Pamela Vo, Nicholas Adlard

|Jun 02, 2023
Comparative efficacy of therapies for relapsing multiple sclerosis: a systematic review and network meta-analysis.

Imtiaz A Samjoo, Christopher Drudge, Sarah Walsh

|Apr 05, 2023
Individual Differences in the Patient Experience of Relapsing Multiple Sclerosis (RMS): A Multi-Country Qualitative Exploration of Drivers of Treatment Preferences Among People Living with RMS.

Sophi Tatlock, Kate Sully, Anjali Batish

|Dec 06, 2022
Evaluating the impact of early vs delayed ofatumumab initiation and estimating the long-term outcomes of ofatumumab vs teriflunomide in relapsing multiple sclerosis patients in Spain.

Umakanth Vudumula, Mausam Patidar, Kapil Gudala

|May 18, 2022
ENTIMOS: A Discrete Event Simulation Model for Maximising Efficiency of Infusion Suites in Centres Treating Multiple Sclerosis Patients.

Kristyna Lacinova, Praveen Thokala, Richard Nicholas

Pageof 2

Frequent Collaborators

5 joint publications

Imtiaz A Samjoo

5 joint publications

Christopher Drudge

4 joint publications

Chris Cameron

4 joint publications

Evelyn Worthington